Your shopping cart is currently empty

NVP-QBE170 is a selective epithelial sodium channel (ENaC) inhibitor with an IC50 of 57.5 nM. It effectively suppresses ENaC function in human bronchial epithelial cells (HBEC), with a prolonged duration of action. NVP-QBE170 significantly decreases ENaC activity in guinea pig airway models and can be utilized for hyperkalemia research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | NVP-QBE170 is a selective epithelial sodium channel (ENaC) inhibitor with an IC50 of 57.5 nM. It effectively suppresses ENaC function in human bronchial epithelial cells (HBEC), with a prolonged duration of action. NVP-QBE170 significantly decreases ENaC activity in guinea pig airway models and can be utilized for hyperkalemia research. |
| Molecular Weight | 755.62 |
| Formula | C30H36Cl2N16O4 |
| Cas No. | 1080018-61-6 |
| Smiles | O=C(NC(=N)NC1CCN(C(=O)C2=CC=C(C=C2)C(=O)N3CCC(NC(=N)NC(=O)C4=NC(Cl)=C(N=C4N)N)CC3)CC1)C5=NC(Cl)=C(N=C5N)N |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.